• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Mad Hedge Fund Trader

AbbVie’s Battle for Arthritis Dominance

Diary, Newsletter

You would think that a company with 60% of the arthritis market would see a soaring stock price. But you would be wrong.

Based on its 2019 performance to date though, AbbVie (ABBV) seems to be on the brink of a disaster. From an impressive 54% gain way back in 2017, the giant pharma stock started to lose ground this year with its share price falling by double-digit percentages. Nevertheless, staunch believers of this stock remain steadfastly optimistic about the company's future.

Here are pretty good reasons why they might be right.

A lot of investors have been wary of AbbVie due to the company's dependence on their blockbuster drug, Humira, which is marketed as a treatment for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis. Since AbbVie derives 60% of its total revenue from the sales of this drug, it's understandable why its shareholders are getting nervous over its declining performance in the market along with the emergence of competitors across the globe.

Surprisingly, AbbVie isn't the least bit worried about Humira.

One of the main reasons for their confidence in Humira's continued dominance in the market is the fact that biosimilar drugs won't be available in the US until around 2023. Given that two-thirds of Humira's sales or roughly $20 billion of its global profits come from the American market, this timeframe gives AbbVie a couple more years to rake in profits from its top drug. In fact, Humira is projected to keep earning as much as $15 billion up until 2024.

Notably, AbbVie has been labeled as a ruthless competitor with its latest move to mark down Humira by up to 89%. This "market poisoning" tactic, as its critics would dub it, has resulted in exits from a number of competitors and would-be competitors aiming to target the Dutch market as well. Hence, Humira might just be able to assert a renewed monopoly in the European nation via their aggressive discounts.

On top of that, AbbVie has lined up a couple of potential blockbuster drugs to take the baton from their beloved Humira. Plaque psoriasis drug Risankizumab along with rheumatoid arthritis treatment Upadacitinib are anticipated to boost AbbVie’s revenues this year as well.

In fact, both treatments are expected to gain FDA approval this year. These drugs, which are estimated to bring in incremental yearly sales of approximately $10 billion, are expected to pick up additional approvals to cater to other autoimmune diseases as well. Using a back-of-the-envelope calculation to add these two potential blockbuster drugs, therefore, puts AbbVie’s incremental risk-adjusted sales at around $35 billion by 2025.

Meanwhile, the company’s other promising products such as blood cancer treatments Imbruvica and Venclexta as well as endometriosis drug Orilissa are doing good in the market.

AbbVie has been exploring the possibility of expanding the indications for Venclexta to cover chronic lymphocytic leukemia (CLL), multiple myeloma, and acute myeloid leukemia (AML). As for Orilissa, this drug is slated to become yet another blockbuster product for AbbVie as it attempts to win approval for the treatment of uterine fibroids. Should Orilissa succeed in this, AbbVie would be poised to become one of the leading companies in the women's health category.

With all these developments and consistent sales from AbbVie, the company is anticipated to post an earnings per share of $2.05 by the next earnings report. If that happens, then the figures would indicate a 9.63% YOY growth for the company.

In managing my portfolio, I always bear in mind the wise words of Warren Buffett: "If you aren't willing to own a stock for 10 years, don't even think about owning it for 10 minutes." At the moment, AbbVie is sold at a bargain with shares trading at lower than eight or nine times its expected earnings. Looking at the company’s pipeline and history of aggressively protecting its moneymaking drugs, it’s clear that AbbVie is poised to provide a significant boost in anyone’s portfolio in the future.

Buy AbbVie on the next market selloff.

https://www.madhedgefundtrader.com/wp-content/uploads/2019/04/humira.png 356 474 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-04-09 01:07:502019-07-09 03:55:23AbbVie’s Battle for Arthritis Dominance
Mad Hedge Fund Trader

April 9, 2019

Tech Letter

Mad Hedge Technology Letter
April 9, 2019
Fiat Lux

Featured Trade:

(THE LEGACY TECH COMPANY THAT’S WORTH BUYING NOW)
(ADBE), (MSFT), (CRM), (AAPL)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-04-09 01:07:172019-04-08 13:49:12April 9, 2019
Mad Hedge Fund Trader

The Legacy Tech Company That's Worth Buying Now

Tech Letter

Adobe (ADBE) will muscle through the upcoming earnings recession.

Tech profits are facing a stiff profit contraction leading to a potential drop of 0.75% next earnings season.

The bulk of the softness will come from, you guessed it, Apple’s (AAPL) debacle selling iPhones in China, alerting investors to take waning sentiment into consideration.   

Adobe is one of your safest bets in 2019 that will experience market dispersion due to the decelerating nature of the global economy.

I feel like a broken record saying the best tech companies to own at this point in the economic cycle are enterprise software stocks benefitting from the migration to digital with bullet-proof balance sheets.

But it must be said.

Shantanu Narayen, President and CEO of Adobe, brilliantly summed up the effects of Adobe’s software by saying, “Adobe is fueling the creative economy, driving the paper-to-digital revolution and enabling businesses to transform through our leadership in customer experience management.”

Adobe, headquartered in San Jose, California, epitomizes the type of software company lapping it up as smaller companies understand the only means of survival is violently pulling the technology lever, particularly juicing up revenue through applying enhanced software.

Shares have exploded over 350% in the past 5 years as small businesses are blown away by Adobe’s dizzying array of creative, marketing, and analytics software, just to name a few.

Adobe shares still have more room to run as the economic cycle has been effectively extended through external macro forces.

A few weeks ago, Adobe reported weak guidance cushioning forecasts down a half notch.

Investors need to understand that the market is grappling with a potential earnings recession on the horizon possibly smothering a large swath of the economy.

Instead of throttling shares on next quarter’s earnings, Adobe felt it was prudent to front run the earnings weakness inherently found in their own model and guide down now.

For the year 2019, Adobe forecasted earnings of $7.80 a share on sales of $11.15B with Digital Media Annual Recurring Revenue (ARR) of approximately $1.5B.

The street forecasts earnings per share of $7.77 on sales of $11.16 billion this year.

The guides weren’t venomous by a long shot and will have no material effect, just a small blip on the radar making Adobe a great bet for beating next quarter’s earnings if they maintain the planned trajectory of expected growth.

Shares have made back up the $10 drop from the subsequent consolidation after the Q1 report, and I suspect that Adobe will run away to new highs going into next quarters earnings report.

It helps that Adobe is blowing away revenue records left and right and announced an audacious project to partner up with Microsoft (MSFT) to mutually bolster sales and marketing software capabilities to take on Salesforce (CRM).

LinkedIn integration will allow Adobe customers to find potential customers for business goods.

If the LinkedIn ad campaign flourishes, the customer will be able to use Microsoft's Dynamics 365 sales software to close the deals.

The precursor to this initiative was Adobe acquiring B2B software firm Marketo for $4.75B last year laying the groundwork for the LinkedIn partnership.

Integrating Magento within the existing Experience Cloud accounts was a meaningful contributor, and Marketo delivered solid results in their full quarter debut under the Adobe portfolio of assets.

In Q1, Adobe pocketed $2.6B in revenue, a 25% improvement YOY resulting in $1.01B of cash flow from operations.

About 91% of revenue stemmed from a recurring source, and Adobe’s biggest division, the Creative division, grew to $1.49B, a 22% YOY improvement.

The $1.49B contributed by the Creative segment comprised of about 2/3 of total quarterly revenue.

The achievement was attributed to new net adds across all offerings, along all geographical fronts, and a ramp-up in subscription-based packages.

Other catalysts were average revenue per user (ARPU) increases, particularly in markets where price optimizations were introduced last year and service adoption including continued momentum with Adobe Stock, which again achieved greater than 20% YOY revenue growth.

The impact of lost deferred revenue stemming from the acquisitions of Magento and Marketo will absorb itself throughout the year creating a tailwind resulting in quarterly operating margins increasing in the second half of the year.

Adobe and Microsoft have proved that dangling useful legacy products such as Adobe’s PDF viewer and Microsoft Office have been perfect gateways into other software upsells like Adobe’s Photoshop and Microsoft’s Azure cloud products.

They have effectively harnessed the same road map to achieve success and don’t apologize for it.

Adobe didn’t have to reset expectations last quarter, but with their highest-grade software growing in the mid-20% and a chance to guide down because of the expected earnings recession, why not take the carrot offered to you?

The software firm is optimally positioned to overperform for the rest of the year, every selloff should be met with furious dip buying for this best of breed software.

I am bullish Adobe.

 

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-04-09 01:06:372019-04-08 14:19:41The Legacy Tech Company That's Worth Buying Now
The Mad Hedge Fund Trader

Using Momentum Stocks to Call the Market

Diary, Newsletter, Research

Hardly a day goes by without a reader asking me which indicators I follow when determining my impeccable market timing.

The short answer is that there are hundreds, and the 50-year accumulation updates real-time 24/7 in my head.

However, there is one in particular indicator that is worth mentioning today. That would be the performance of momentum stocks.

Momentum stocks are shares that deliver a larger move in price, or beta, than the market as a whole.

They tend to be the shares of high growth companies that deliver a reliable stream of positive earnings surprises.

In fact, they have earned a large following of traders, known as ‘momentum investors.”

Call them the canaries in the coal mine.

Look at the list of top ten holdings below, and you will find many that you know and love, and are often the subject of Mad Hedge Fund Trader Trade Alerts.

Momentum stocks are attractive because they substantially outperform a more sedentary index, like the S&P 500 (SPY).

Momentum stocks can be a great leading indicator for the stock market as a whole.

When momentum stocks take off like a scalded chimp, it is a good idea to adopt a “RISK ON” approach towards all of your asset selections.

When momentum stocks fail to reach new highs, it is a warning signal that the party is about to end and “RISK OFF” assets are about to gain favor.

This is why I always keep a close eye on momentum stocks when assembling my own trading book.

There is one really easy way to follow momentum stocks and that is to watch the iShares MSCI USA Momentum Factor ETF (MTUM) like a hawk.

The (MTUM) seeks to track the performance of an index that measures the performance of 122 U.S. large and mid-capitalization stocks exhibiting relatively higher momentum characteristics than the main market before fees and expenses.

This portfolio is then rebalanced every six months to reflect new market trends and to deep six the losers.

If you want to see how well this works, just take a look at the chart below.

The (MTUM) is particularly attractive because its 0.15% expense ratio is the lowest among the several offerings in the marketplace.

The fund currently has $8.56 billion in assets, so the institutional community takes it seriously. 

The trailing 30-day SEC yield is only 1.31%, reflecting the fact that many of its holdings are non-dividend paying technology and health care stocks.

To learn more about the details of the (MTUM) please click here. 
 
And what are momentum stocks telling us right now?

That they have just had an incredible three-month run and are long overdue for a rest.

Just thought you’d like to know.

 

Exposure Breakdown


MTUM Top 10 Holdings

Rocket

https://www.madhedgefundtrader.com/wp-content/uploads/2016/03/MTUM-Top-10-Holdings-e1457047929618.png 170 400 The Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png The Mad Hedge Fund Trader2019-04-09 01:06:302019-07-09 03:55:34Using Momentum Stocks to Call the Market
Mad Hedge Fund Trader

April 9, 2019 - Quote of the Day

Tech Letter

“The Internet has always been, and always will be, a magic box.” – Said Venture Capitalist Marc Andreessen

https://www.madhedgefundtrader.com/wp-content/uploads/2018/09/Marc-Andreessen.png 477 279 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-04-09 01:05:592019-04-08 13:45:05April 9, 2019 - Quote of the Day
MHFTR

April 9, 2019 - Quote of the Day

Diary, Newsletter, Quote of the Day

"There is no disinfectant like success," said Daniel Boorstin, the 12th Librarian of Congress.

https://www.madhedgefundtrader.com/wp-content/uploads/2017/06/kid.jpg 296 202 MHFTR https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png MHFTR2019-04-09 01:05:542019-04-09 00:10:49April 9, 2019 - Quote of the Day
Mad Hedge Fund Trader

Mad Hedge Hot Tips for April 8, 2019

Hot Tips

Mad Hedge Hot Tips
April 8, 2019
Fiat Lux

The Five Most Important Things That Happened Today
(and what to do about them)

 

1) Pinterest Launches a Down Round. With an IPO target of $9 billion compared to $12 billion in their last venture capital valuation, the IPO market is deflating very quickly. The weak (LYFT) post-market trading is the cautionary tale. Click here.

2) Boeing Shares Slammed, down 5%, on latest production cutback. Crash disruption may now extend to 6-9 months, and earnings cut 13%. We might get a second bite of the apple. Buy (BA) on the next order cancelation. Click here.

3) GE Gets Slaughtered, with an earnings downgrade from Morgan Stanley. It will take years to sort out this mess. Avoid (GE). Click here.

4) Copper Demand is Rocketing, off of soaring global electric car production. Each vehicle needs 22 pounds of the red metal, and 4 million have been built so far. Take a second bite of the apple with (FCX) as well. Click here.

5) The 30-Year Mortgage Plunges to 4.03%, and may save the spring selling season for residential real estate. Click here.
 

Published today in the Mad Hedge Global Trading Dispatch and Mad Hedge Technology Letter:

(MARKET OUTLOOK FOR THE WEEK AHEAD, OR THE FLIP-FLOPPING MARKET),

(SPY), (TLT), (TSLA), (BA), (LUV), (DAL),

(THE BATTLE FOR COFFEE IN CHINA),

(SBUX), (MSFT), (AAPL), (IBM)

 

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-04-08 16:18:002019-04-08 16:18:01Mad Hedge Hot Tips for April 8, 2019
Mad Hedge Fund Trader

April 8, 2019 - MDT Pro Tips A.M.

MDT Alert

While the Diary of a Mad Hedge Fund Trader focuses on investment over a one week to a six-month time frame, Mad Day Trader, provided by Bill Davis, will exploit money-making opportunities over a brief ten minute to three-day window. It is ideally suited for day traders, but can also be used by long-term investors to improve market timing for entry and exit points. Read more

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-04-08 09:03:042019-04-08 09:03:04April 8, 2019 - MDT Pro Tips A.M.
Mad Hedge Fund Trader

April 8, 2019

Tech Letter

Mad Hedge Technology Letter
April 8, 2019
Fiat Lux

Featured Trade:

(THE BATTLE FOR COFFEE IN CHINA)
(SBUX), (MSFT), (AAPL), (IBM)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-04-08 08:07:482019-04-08 08:30:34April 8, 2019
Mad Hedge Fund Trader

The Battle for Coffee in China

Tech Letter

If you ask me what you should sample at a Starbucks in China - I would say nothing.

Starbucks has become successful on the back of selling bad tasting coffee to the Chinese.

Even more peculiar, the CEO of Starbucks Kevin Johnson has been captaining the ship since 2017.

After watching Johnson's interview with Bloomberg, I fully believe he is not adequately prepared for what the future beholds.

Let me explain why.

Johnson started at IBM (IBM) in the 80s as an engineer, but he hasn't been an engineer for the last 20 odd years.

In the early 2000s, he became a salesman at Microsoft (MSFT), and his interview revealed that he is still a salesman at heart.

He continued to refer back to his engineering background, yet the know-how he accumulated in the 80s at IBM has little relevance to the “move fast and break things” environment of today.

Johnson was groomed under the tutelage of Microsoft’s Steve Ballmer at Microsoft, a salesman, who almost sunk Microsoft during his tenure.

Anyone who trained under Steve Ballmer is someone that would need to walk across fiery embers to prove his or her viability.

The interview with Bloomberg felt like an inauthentic marketing video, with Johnson regurgitating salesman rhetoric with little substance.

As Starbucks shreds the bear story of naysayers to make new all-time highs, there are serious icebergs ahead because of disruptive technological start-ups.

Starbucks has relied on emerging markets as its growth engine inaugurating 612 stores in China last year, and another 600 will come online before 2022.

Selling bad coffee to Chinese will be more difficult going forward.

The prominent tea drinking nation had no idea what good coffee tasted like 10 years ago.

Even recently, many Chinese thought instant coffee packaged in those convenient stick-shaped packets was high-grade coffee.

The last five years has seen an unmitigated onslaught of Chinese international tourism mainly flowing to Europe, Canada, Australia, and America.

Not only did Chinese shop until their panties dropped, but they began to become more inclined to understand culinary and cultural aspects of foreign cultures like, for instance, how good coffee should taste among other cultural trappings.

Five years ago, Chinese also went to Starbucks to sample the coffee. Now, they go to Starbucks because the interiors are comfortable making it a plausible place for an impromptu business meeting in a downtown or business district location.

Let’s remember that Starbucks could never crack the Italian market because teaching Italians how to make coffee doesn’t sell in Italy.

It took until last September to open the first Starbucks in the cultural center of Milan, Italy, and I can tell you that it’s not a regular, cookie cutter Starbucks.

The Milan Starbucks is billed as a “Reserve Roastery” with marble finishes contributed from the supplier that up until now was only used to build the famed Duomo of Milan and buildings in the surrounding Piazza. 

To say this Starbucks is posh is an understatement.

The 25,000-square-foot coffee shop delivers small-batch roastings of exotic coffees from more than 30 countries, and artisanal food from the local culinary rock star, Rocco Princi.

In fact, Starbucks built it into a four-star restaurant with expensive cocktails and the whole shebang.

Understandably, the average revenue per user (ARPU) at the Italian roastery earns 400% more than the average American Starbucks shop.

This is what Starbucks had to do to get their first footprint into Italy, while coffee know-how isn’t up to that level in China, differentiating variables will be harder to discover moving forward as Chinese customers look to handcrafted, artisanal options demanding a superior customer experience.

The generic Starbucks in China sells mediocre black coffee made from inferior beans for $5 per cup, a far cry from the reserve roastery in Milan.

If you get into the creamier, frothy types of drinks, then price points shoot up to $6 or $7.

Meet the current tech disruptor of coffee business in China, Luckin Coffee headed by Chinese tech entrepreneur Qian Zhiya.

Her impressive resume spans from COO of Shenzhou, a car rental app and website, to Co-founder of UCAR, a ride-hailing service spun off from Shenzhou.

During the Bloomberg interview, Kevin Johnson bragged that Starbucks is opening a new Chinese Starbucks every 15 hours.

He forgot to mention Starbucks' local competitor opens a new Luckin Coffee every 8 hours amounting to about 3 per day.

Luckin Coffee's plan is to open 1,950 more stores in the next 18 months.

This has the inklings of a dogfight down to zero with a local upstart, and ask how that turned out for Facebook, Google, or even Amazon in China.

Every FANG except Apple (AAPL) cease to exist in China now, and brewing bad coffee doesn’t create the positive network effect that Apple has in China, effectively delivering an additional 4 million ancillary jobs connected to the iOS system.

The entrenched nature of Apple in China means they cannot be removed without catastrophic job losses to local Chinese triggering massive social unrest.

In the case of Starbucks, every location that folds, employees can walk across the street to join a Luckin Coffee franchise, such is an environment in a zero-sum game.  

Qian envisions coffee shops like a tech empire because of her background, and has earmarked fresh capital for product R&D, technology innovation, and business development.

Luckin is hellbent on capturing young office workers with its locations, delivery services, and low prices, operating a no-frills type of Starbucks alternative.

They have undercut Starbucks pricing by offering the same cup of Americano $5 coffee for $3.15.

How about their expansion plans?

Locations will explode to 4,500 by the end of 2019 which will eclipse the number of Chinese Starbucks in mid-2019.

The company has relied on technology, over half of the locations lack physical seating, shrinking space by way of applying kiosk structures as a coffee preparation station before customers access delivery orders through the smartphone app.

Digital payments are common via WeChat or Luckin’s own “coffee wallet,” and over 70% of digital customers are under 30.

Luckin's strategy is a far cry from the plush sofas of Starbucks' home away from home strategy. Distinctively, Luckin does not want customers to lounge around and talk business.

The rise of Luckin Coffee coincides with hamstringing Starbucks' comparable-store sales growth rising just 1%, with a 2% decline in transactions, down from 6% sales growth the prior Q1.

CFO Patrick Grismer did what CEO Kevin Johnson could not, admitting, “we have to acknowledge that competition is intensifying.”

Luckin Coffee burned through more than $100 million in cash in 2018, and like the prototypical tech company, will burn more cash to intensify competition with Starbucks.

I predict they will head further into deeper coffee discounts to snatch market share.

Other possible pain points for Starbucks that Qian could exploit are more subsidized deliveries which could continue for another “3-5 years” but could be extended if need be.

Qian is content with her model, stating she is “in no rush to make a profit,” signaling convenient access to a trove of generous debt instruments.

The best-case scenario in 2019 is that Starbucks' profit margins shrink or stagnate in China, the worst case, they lose significant Chinese market share and tier 1 city franchises continue to cannibalize revenue.

Starbucks' golden years in China are over and you can thank technology for offering a model to compete with them.

If Starbucks' shares continue moving up, it won’t be for much longer.  

 

 

https://www.madhedgefundtrader.com/wp-content/uploads/2019/04/luckin-coffee.png 593 974 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-04-08 08:06:452019-04-08 08:30:11The Battle for Coffee in China
Page 12 of 17«‹1011121314›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top